These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3520171)

  • 1. Current status of renal transplantation--1986.
    Sterioff S; Engen DE; Zincke H
    Mayo Clin Proc; 1986 Jul; 61(7):573-8. PubMed ID: 3520171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kinetics of serum soluble HLA-A, B and DR antigens on human renal allografts].
    Shiramizu T
    Fukuoka Igaku Zasshi; 1983 Dec; 74(12):787-95. PubMed ID: 6373538
    [No Abstract]   [Full Text] [Related]  

  • 3. HLA-matching and pretransplant blood transfusions in cadaveric renal transplantation--a changing picture with cyclosporin.
    Lundgren G; Groth CG; Albrechtsen D; Brynger H; Flatmark A; Frödin L; Gäbel H; Husberg B; Klintmalm G; Maurer W
    Lancet; 1986 Jul; 2(8498):66-9. PubMed ID: 2873380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 7. The importance of tissue typing in cadaveric kidney transplantation (pros).
    Sirchia G
    Contrib Nephrol; 1982; (34):101-10. PubMed ID: 6756776
    [No Abstract]   [Full Text] [Related]  

  • 8. Prospective DR matching for first cadaver donor renal allografts and retransplantation.
    Lucas BA; Jennings CD; Thompson JS; Flanigan RC; McRoberts JW; Holland NH
    Transplantation; 1985 Jan; 39(1):39-44. PubMed ID: 3880964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [4-way immunosuppression in pre-sensitized recipients of allogenic cadaver kidney transplants].
    Oesterwitz H; May G; Müller P; Strobelt V; Seeger W; Seibt F; Horlbeck R; Hansen C
    Z Urol Nephrol; 1990 Jan; 83(1):1-8. PubMed ID: 2184625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uses of antilymphocyte globulin in renal transplantation.
    Novick AC
    Urol Clin North Am; 1983 May; 10(2):253-62. PubMed ID: 6344386
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation of kidneys from living related donors. Comparison with cadaveric kidney transplantation.
    Thomson NM; Atkins RC; Scott DF; Marshall VC; McGinley E; Holdsworth SR; Ironside W
    Med J Aust; 1983 Dec 10-24; 2(12):609-12. PubMed ID: 6366497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up in London Transplant Group recipients of cadaver renal allografts. The influence of HLA matching on transplant outcome.
    Festenstein H; Doyle P; Holmes J
    N Engl J Med; 1986 Jan; 314(1):7-14. PubMed ID: 3510010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved results of cadaver renal transplantation in the diabetic patient.
    Khauli RB; Novick AC; Braun WE; Steinmuller D; Buszta C; Goormastic M
    J Urol; 1983 Nov; 130(5):867-70. PubMed ID: 6355509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation.
    Koo DD; Welsh KI; McLaren AJ; Roake JA; Morris PJ; Fuggle SV
    Kidney Int; 1999 Oct; 56(4):1551-9. PubMed ID: 10504507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
    Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
    Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report.
    Moen T; Berger L; Goyer K; Dahl O; Thorsby E
    Scand J Urol Nephrol Suppl; 1981; 64():30-7. PubMed ID: 6815792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.